The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CLARITY-PanTumor01: A phase 2 trial of the claudin 18.2-specific antibody-drug conjugate AZD0901 (CMG901) in patients with CLDN18.2-expressing advanced solid tumors.
 
Alexander G Raufi
No Relationships to Disclose
 
Lipika Goyal
Consulting or Advisory Role - Abbvie; Alentis Therapeutics; AstraZeneca; Black Diamond Therapeutics; Blueprint Medicines; Cogent Biosciences; Compass Therapeutics; Eisai/H3 Biomedicine; Exelixis; Genentech; Incyte; Kinnate Biopharma; Merck; QED Therapeutics; SERVIER; Sirtex Medical; Surface Oncology; Synthekine; Taiho Pharmaceutical; TransThera Biosciences; Tyra Biosciences
Research Funding - Alyssum (Inst); Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - Agios; Boehringer Ingelheim; Boehringer Ingelheim; Debiopharm Group; Merck; Taiho Pharmaceutical
 
Elizabeth Smyth
Employment - HCA International
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer; SERVIER
Consulting or Advisory Role - Amal Therapeutics; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Merck Serono; Novartis; Roche; SERVIER; Turning Point Therapeutics; Viracta Therapeutics; Zymeworks
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Amgen
 
Philip Szekeres
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca; Lilly
 
Marcella Petrone
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Honoraria - AstraZeneca
Research Funding - AstraZeneca
 
Rosalind Hobson
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Kenneth Thress
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Makoto Origuchi
Employment - AstraZeneca; Novartis (I)
 
Jyoti Nehra
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Jessica S Brown
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Rakesh Kumar
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Patents, Royalties, Other Intellectual Property - AstraZeneca
 
Italia Grenga
Employment - AstraZeneca; Novartis
Stock and Other Ownership Interests - AstraZeneca; Novartis
Patents, Royalties, Other Intellectual Property - AstraZeneca
 
Yelena Y. Janjigian
Stock and Other Ownership Interests - Inspirna
Honoraria - Abbvie; AmerisourceBergen; Arcus Biosciences; AskGene Pharma; Astellas Pharma; AstraZeneca; Basilea Pharmaceutical; Bayer; Bristol-Myers Squibb; Clinical Care Options; Daiichi Sankyo; Ed Med Resources (OncInfo); Eisai; Geneos; Genzyme; GlaxoSmithKline; Guardant Health; H.C. Wainwright & Co.; HMP Education; Imedex; Imugene; Inspirna; Lilly; Lynx Health; Master Clinician Alliance; Merck; Merck Serono; Mersana; Michael J. Hennessy Associates; Paradigm; Peerview; Pfizer; Physicians' Education Resource, LLC; Research to Practice; Seagen; Silverback Therapeutics; Zymeworks
Consulting or Advisory Role - Abbvie; AmerisourceBergen; Arcus Biosciences; AskGene Pharma; Astellas Pharma; AstraZeneca; Basilea Pharmaceutical; Bayer; Bristol-Myers Squibb; Clinical Care Options; Daiichi Sankyo; Ed Med Resources (OncLive); Eisai; Geneos; Genzyme; GlaxoSmithKline; GlaxoSmithKline; Guardant Health; H.C. Wainwright & Co.; HMP Education; Imedex; Imugene; Inspirna; Jazz Pharmaceuticals; Lilly; Lynx Health; Merck; Merck Serono; Mersana; Michael J. Hennessy Associates; Paradigm; Peerview; Pfizer; Physicians' Education Resource, LLC; Research to Practice; Seagen; Silverback Therapeutics; Zymeworks
Research Funding - Arcus Biosciences (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Cycle for Survival (Inst); Department of Defense (Inst); Fred's Team (Inst); Genentech/Roche (Inst); Inspirna (Inst); Lilly (Inst); Merck (Inst); NCI (Inst); Stand up to Cancer (Inst); Transcenta (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb Japan; Merck
Other Relationship - Axis Medical Education; Clinical Care Options; Research to Practice
 
Kohei Shitara
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Lilly; Ono Pharmaceutical
Consulting or Advisory Role - ALX Oncology; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Guardant Health; MSD; Novartis; Ono Pharmaceutical; Takeda; Zymeworks
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); MSD (Inst); Ono Pharmaceutical (Inst); PRA Health Sciences (Inst); Taiho Pharmaceutical (Inst)